New rabies vaccine could cut shots from three visits to one
NCT ID NCT07168018
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new experimental rabies vaccine (ChAdOx2 RabG) given together with the standard rabies vaccine in healthy adults aged 18-45. The goal is to see if this combination is safe and produces a strong immune response, potentially allowing a single visit instead of the usual three. Forty participants in a rabies-endemic country will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ChAdOx2 RabG (experimental rabies vaccine) and inactivated rabies vaccine (Verorab)
- What this could lead to
- If successful, this could lead to a simpler, single-visit rabies vaccination schedule, improving access in endemic areas.
- What could go wrong
- This is an early phase II trial with only 40 participants, so results may not apply broadly. Safety and immune response are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ifakara Health Institute
Bagamoyo, Tanzania
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental antibody cocktail offers hope for rabies patients with no other options
- New antibody cocktail aims to stop rabies after multiple dog bites
- New vaccines for yellow fever and rabies enter first human tests
- New rabies vaccine shows promise in large trial
- Could a tiny skin shot replace the big rabies needle?
- New rabies shot shows promise in preventing deadly infection after bites